Dna X (SONM) Profit After Tax (2018 - 2026)

Dna X (SONM) has 9 years of Profit After Tax data on file, last reported at $6.3 million in Q1 2026.

• Quarterly Profit After Tax rose 759.73% year-over-year to $6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (up 93.46% YoY) and the FY2025 annual result came in at -$8.0 million, up 76.36% from the prior year.
• Profit After Tax grew to $6.3 million in Q1 2026, from $3.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $6.3 million in Q1 2026 to a low of -$21.6 million in Q4 2024.
• A 5-year average of -$3.0 million and a median of -$1.6 million in 2022 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2024 — Profit After Tax sank 1497.49% — and 2026, when it soared 759.73%.
• Tracing SONM's Profit After Tax over 5 years: stood at -$1.0 million in 2022, then retreated by 29.85% to -$1.4 million in 2023, then slumped by 1497.49% to -$21.6 million in 2024, then soared by 117.65% to $3.8 million in 2025, then surged by 66.19% to $6.3 million in 2026.
• The last three Profit After Tax figures came in at $6.3 million (Q1 2026), $3.8 million (Q4 2025), and -$4.8 million (Q3 2025), per Business Quant data.